BASAGLAR

eli lilly canada inc🇨🇦 Health Canada

Approval Id: 4844682514caf3ba
Drug Approval Canada Name: BASAGLAR
Product Name: BASAGLAR
Status: Marketed
Status Date: 2017-08-18
Original Market Date: 2017-08-18
Din: 02461528
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D
Ahfs: 68:20.08
Atc Original: A10AE04 INSULIN GLARGINE
Atc Name: a 10 ae 04
Aig Number: 0147062001
Company Name: eli lilly canada inc
Company Address: SUITE 900, Exchange Tower, 130 King Street West, Toronto, Ontario, Canada, M5X 1B1

INSULIN GLARGINE

100 UNIT / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

4844682514caf3ba

Type

Standard